60 stories · Updated May 28, 2026
Reading Time: 10 minutesClinicians managing male hypogonadism and metabolic syndrome need to understand the latest FDA stance on safety, cardiovascular risk, and indications for T
Reading Time: 4 minutesFor patients living with autoimmune hepatitis, a chronic and often debilitating liver condition, the promise of new treatments offers significant hope. However, the path from scientific discovery to patient access is fraught...
Reading Time: 4 minutesIn a significant move for obesity care, Novo Nordisk, the manufacturer of Wegovy (semaglutide), has rolled out a new multi-month subscription program for its popular FDA-approved GLP-1 treatment. This initiative, touted as...
Reading Time: 4 minutesFor millions of Americans relying on Medicare Advantage (MA) plans, understanding the quality of their healthcare options is paramount. The Centers for Medicare & Medicaid Services (CMS) recently finalized its Contract Year...